Prophylactic pancreatic stent placement to prevent pancreatitis after ERCP
- 11 January 2024
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 403 (10425) , 411-413
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trialThe Lancet, 2024
- American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendationsGastrointestinal Endoscopy, 2022
- Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trialThe Lancet Gastroenterology & Hepatology, 2021
- Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysisEndoscopy, 2020
- Effect of Endoscopic Sphincterotomy for Suspected Sphincter of Oddi Dysfunction on Pain-Related Disability Following CholecystectomyJAMA, 2014
- Similar Efficacies of Biliary, With or Without Pancreatic, Sphincterotomy in Treatment of Idiopathic Recurrent Acute PancreatitisGastroenterology, 2012
- A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP PancreatitisNew England Journal of Medicine, 2012
- Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trialEndoscopy, 2011
- Is There Any Difference in Outcomes Between Long Pigtail and Short Flanged Prophylactic Pancreatic Duct Stents?Digestive Diseases and Sciences, 2010
- Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ductsEndoscopy, 2009